Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters

European Journal of Pharmacology

Volumn 361, Issue 2-3, 1998, Pages 269-275

  Kokoshka, Jerry M ^a   Vaughan, Roxanne A ^b   Hanson, Glen R ^a   Fleckenstein, Annette E ^a  

^a UNIVERSITY OF UTAH   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Dopamine; Dopamine transporter; Methamphetamine

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DOPAMINE TRANSPORTER; METHAMPHETAMINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE UPTAKE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIGAND BINDING; MALE; NONHUMAN; NUCLEUS ACCUMBENS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT; SYNAPTOSOME;

ANIMALS; CARRIER PROTEINS; COCAINE; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHAMPHETAMINE; NERVE TISSUE PROTEINS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032553621     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00741-9     Document Type: Article

References (41)

1. Axt K.J., Commins D.L., Vosmer G., Seiden L.S. alpha-Methyl-p-tyrosine pretreatment partially prevents methamphetamine-induced neurotoxin formation. Brain Res. 515:1990;269-276.
2. Berman S.B., Zigmond M.J., Hastings T.G. Modification of dopamine transporter functions: effect of reactive oxygen species and dopamine. J. Neurochem. 67:1996;593-600.
3. 3H] dopamine uptake is similar in both the rat striatum and nucleus accumbens Eur. J. Pharmacol. 173:1989;215-217.
4. Brunswick D.J., Benmansour S., Tajani-Butt S.M., Hauptmann M. Effects of high-dose methamphetamine on monoamine uptake sites in rat brain measured by quantitative autoradiography. Synapse. 11:1992;287-293.
5. Copeland B.J., Vogelsberg V., Neff N.H., Hadjiconstantinou M. Protein kinase C activators decrease dopamine uptake into striatal synaptosomes. J. Pharmacol. Exp. Ther. 277:1996;1527-1532.
6. Eisch A.J., Gaffney M., Weihmuller F.B., O'Dell S.J., Marshall J.F. Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine. Brain Res. 598:1992;321-326.
7. Fleckenstein A.E., Kopajtic T.K., Carroll F.I., Boja J.W., Kuhar M.J. Highly potent cocaine analogs cause long-lasting increases in locomotor activity. Eur. J. Pharmacol. 311:1996;109-114.
8. Fleckenstein A.E., Pogun S., Carroll F.I., Kuhar M.J. Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 {3-beta-(3-p-chlorophenyl)tropan-2-beta-carboxylic acid p-isothiocyantophenylethyl ester hydrochloride}. J. Pharmacol. Exp. Ther. 279:1996;200-206.
9. Fleckenstein A.E., Metzger R.R., Beyeler M.B., Gibb J.W., Hanson G.R. Oxygen radicals diminish dopamine transporter function in rat striatum. Eur. J. Pharmacol. 334:1997;111-114.
10. Fleckenstein A.E., Metzger R.R., Wilkins D.G., Gibb J.W., Hanson G.R. Rapid and reversible effects of methamphetamine on dopamine transporters. J. Pharmacol. Exp. Ther. 282:1997;834-838.
11. Fleckenstein A.E., Wilkins D.G., Gibb J.W., Hanson G.R. Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration. J. Pharmacol. Exp. Ther. 283:1997;281-285.
12. Giambalvo C.T. Protein kinase C and dopamine transport: 1. Effects of amphetamine in vivo. Neuropharmacology. 31:1992;1201-1210.
13. Gibb J.W., Kogan F.J. Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity. Naunyn-Schmiedeberg's Arch. Pharmacol. 310:1979;185-187.
14. Giovanni A., Liang L.P., Hastings T.G., Zigmond M.J. Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J. Neurochem. 64:1995;1819-1825.
15. Graham D.G. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14:1978;633-643.
16. Hotchkiss A.J., Gibb J.W. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214:1980;257-262.
17. max. J. Neurochem. 68:1997;225-232.
18. Kitayama S., Shimada S., Xu H., Markham L., Donovan D.M., Uhl G.R. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc. Natl. Acad. Sci. USA. 89:1992;7782-7785.
19. Kitayama S., Dohi T., Uhl G.R. Phorbol esters alter functions of the expressed dopamine transporter. Eur. J. Pharmacol. 268:1994;115-119.
20. Kokoshka J.M., Metzger R.R., Wilkins D.G., Gibb J.W., Hanson G.R., Fleckenstein A.E. Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain. Brain Res. 799:1998;78-83.
21. Kondo T., Ito T., Sugita Y. Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuates dopamine depletion in mouse striatum. Ann. NY Acad. Sci. 738:1994;222-229.
22. Lee F.J., Pristupa Z.B., Ciliax B.J., Levey A.J., Niznik H.B. The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain. J. Biol. Chem. 271:1996;20885-20894.
23. Lew R., Patel A., Vaughan R.A., Wilson A., Kuhar M.J. Microheterogeneity of dopamine tranpsorters in rat striatum and nucleus accumbens. Brain Res. 584:1992;266-271.
24. McPherson, G.A., 1986. EBDA-Kinetic-Lowry. Elsevier-Biosoft. Cambridge, UK.
25. Morgan M.E., Gibb J.W. Short-term and long-term effects of methamphetamine on biogenic amine metabolism in extra-striatal dopaminergic nuclei. Neuropharmacology. 19:1980;989-995.
26. Munson P.J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:1980;220-239.
27. Peat M.A., Warren P.F., Gibb J.W. Effects of a single dose of methamphetamine and iprindole on the serotonergic and dopaminergic system of the rat brain. J. Pharmacol. Exp. Ther. 225:1983;126-131.
28. 3H] dopamine uptake Brain Res. 641:1994;83-91.
29. Ricaurte G.A., Guillery R.W., Seiden L.S., Schuster C.R., Moore R.Y. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235:1982;93-103.
30. Schmidt C.J., Gibb J.W. Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: Effects of amfonelic acid. Eur. J. Pharmacol. 109:1985;73-80.
31. Schmidt C.J., Ritter J.K., Sonsalla P.K., Hanson G.R., Gibb J.W. Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233:1985;539-544.
32. Vaughan R.A. Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping. Mol. Pharmacol. 47:1995;956-964.
33. Vaughan R.A., Uhl G., Kuhar M.J. Recognition of dopamine transporters by antipeptide antibodies. Mol. Cell. Neurosci. 4:1993;209-215.
34. Vaughan R.A., Huff R.A., Uhl G.R., Kuhar M.J. Protein kinase C-mediated phosphorylation and functional regulation in striatal synaptosomes. Biol. Chem. 272:1997;15541-15546.
35. 11C ]WIN-35,428 positron emission tomography studies and direct in vitro determinations J. Neurosci. 18:1998;419-427.
36. Wagner G.C., Ricaurte G.A., Seiden L.S., Schuster C.R., Miller R.J., Westley J. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 181:1980;151-160.
37. Wagner G.C., Lucot J.B., Schuster C.R., Seiden L.S. Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes. Brain Res. 270:1983;285-288.
38. Wilson J.M., Kalasinsky K.S., Levey A.I., Bergeron C., Reiber G., Anthony R.M., Schmunk G.A., Shannak K., Haycock J.W., Kish S.J. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nature Med. 2:1996;699-703.
39. Woolverton W.L., Ricaurte G.A., Forno L.S., Seiden L.S. Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res. 486:1989;73-78.
40. Zhang L., Reith M.E. Regulation of the functional activity of the human dopamine transporter by the arachidonic acid pathway. Eur. J. Pharmacol. 315:1996;345-354.
41. Zhang L., Coffey L.L., Reith M.E. Regulation of the functional activity of the human dopamine transporter by protein kinase C. Biochem. Pharmacol. 53:1997;677-688.